New Podcast on Drug Pricing Reform Myths and Realistic Solutions

A new episode of the Patients Rising Podcast series is now available. In this installment, Chief Science Policy Officer at the Global Health Living Foundation Robert Popovian discusses prescription drug pricing reform. He’s joined by Pam Kohl, a patient advocate, and Kathi Luis of the Amyloidosis Foundation. Much attention has been given to policies proposing lower drug prices, but many of these proposals will fail to positively impact patients.

“We sort through the facts and myths of drug pricing, how “middlemen” in the supply chain lead to higher costs and real solutions to lowering out-of-pocket costs for patients. Clinical pharmacist and health economist Dr. Robert Popovian dives into the complicated world of drug pricing and simply explains how it impacts patients’ health and pockets.” Listen to the podcast here.

(Source: Patients Rising Podcast, 10/22/21)